SUBSCRIBE
SUBSCRIBE

Pliant Therapeutics, Inc.

NEWS
Biotech Bay
Pliant Therapeutics Snags $62 Million
Two months after unveiling a new approach to identify novel biomarkers for the detection and treatment of idiopathic pulmonary fibrosis, South San Francisco-based Pliant Therapeutics secured $62 million in a Series B financing round to support its research programs.
July 16, 2018
 · 
2 min read
 · 
Alex Keown
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Pliant Therapeutics
Business
What You Need to Know About Pliant
January 3, 2017
 · 
3 min read
Pliant Therapeutics Launches in the Bay Area With $45 Million and former Johnson & Johnson and Celgene Execs At the Wheel
Business
Pliant Launches in the Bay Area With $45 Million and Former Johnson & Johnson and Celgene Execs At the Wheel
February 18, 2016
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Press Releases
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 22, 2025
January 23, 2025
 · 
2 min read
Press Releases
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer
January 22, 2025
 · 
6 min read
Press Releases
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
 · 
1 min read
Press Releases
Pliant Therapeutics to Participate in Upcoming Investor Events
November 21, 2024
 · 
2 min read
Press Releases
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
November 19, 2024
 · 
4 min read
Press Releases
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 8, 2024
 · 
8 min read
Press Releases
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
November 6, 2024
 · 
1 min read
Press Releases
Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024
October 17, 2024
 · 
6 min read
Business
Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
October 1, 2024
 · 
3 min read
Press Releases
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2024
October 1, 2024
 · 
2 min read
Load More